Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2025 –2032 | |
|
|
USD 1.52 Billion |
| USD 2.28 Billion | |
| % | |
Latin America Point of Care Infectious Disease Market Segmentation, By Type (Products and Services), Technology (Immunodiagnostics, Molecular Diagnostics, Dipsticks, Microfluidics and Others), Application (Tropical Diseases, Sexually Transmitted Disease, Respiratory Disorders, Liver Disorders, Inflammatory Diseases, Hospital Acquired Infections (HAIS), GI Infections, CNS Infections, Cardiovascular Infection and Others), Availability (Over-the-Counter (OTC) Testing Kits and Prescription-Based Testing Kits), End Users (Homecare Setting, Hospitals, Diagnostic Centres, Outpatient Healthcare Setting and Others), Distribution Channel (Direct Tenders and Retail Sales) - Industry Trends and Forecast to 2032
Testing that may be done in close proximity to the patient and allows a medical decision to be made immediately away based on the results and monitoring is known as point-of-care testing. Doctors can examine reliable real-time, lab-quality diagnostic data in minutes rather than hours using point-of-care testing (POCT), also known as with-patient testing. It ensures that patients receive the most effective and efficient treatment available, whenever and wherever they require it.
Latin America point of care infectious disease market size was valued at USD 1.52 billion in 2024 and is projected to reach USD 2.28 billion by 2032, with a CAGR of 5.24% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Point of Care Infectious Disease Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Abbott (U.S), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S), Danaher (U.S), Sekisui Diagnostics (U.S), Trinity Biotech (Ireland), bioMérieux (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S), Beckman Coulter, Inc. (U.S), PTS Diagnostics (U.S), Nova Biomedical (U.S), Chembio Diagnostics, Inc. (U.S), Quidel Corporation (U.S) and Sienco, Inc (U.S)
|
|
Market Opportunities
|
|
Point of Care Infectious Disease Market Definition
Point-of-care tests are not as popular as central laboratory testing, because of their limited volume and high cost. This places additional load on the billing system, as POC testing require different codes. This could lead to billing errors by unskilled or freshly employed staff and data entry failure due to mismatched test codes in the data management system.
Point of Care Infectious Disease Market Dynamics
Drivers
Over the projection period, cost-effective technology for efficient and accurate disease screening, diagnosis, and monitoring, together with government initiatives to restrict disease transmission and improve healthcare facilities, is likely to be a key driver.
Furthermore, an increase in the senior population, which is more susceptible to infections and other ailments, is predicted to raise demand for healthcare monitoring and diagnostic devices in home care and assisted living. In addition, the incidence of diabetes, cardiac disease, drug misuse, and STDs in developing nations and the occurrence of chronic and endemic diseases like Chagas in less developed regions is predicted to boost market potential.
As the prevalence of infectious diseases in Latin America has increased, numerous healthcare organisations and governments have implemented screening programmes and plans to control and eradicate these diseases. The Latin America point of care diagnostics market is predicted to be driven by gradually developing economies, increased spending power among the population, high disease prevalence, and increased medical knowledge over the forecast period.
Opportunities
The whole point of care infectious disease market is expected to rise in the future as healthcare and medical professionals need more automated point of care infectious disease techniques. Government initiatives and measures promoting the benefits of point-of-care infectious illness could help to increase the point-of-care infectious disease business in the coming years. The point of care infectious disease business is seeing increased demand as people become more aware of the necessity of diagnostic tests and as their disposable incomes rise.
Restraints/Challenges
The point of care testing market shows sluggish growth due to the stringent and time-consuming regulatory policies. With the expanding area of use and increased adoption in developing economies, regulators are placing a greater emphasis on point-of-care testing (POCT) compliance, safety, and usability. Point-of-care testing are classed as class II medical devices by the US Food and Drug Administration. These devices provide a reasonable guarantee of the device's effectiveness and safety.
This point of care infectious disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care infectious disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The point of care infectious disease market is segmented on the basis of type, technology, availability, application, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Technology
Application
Availability
End Users
Distribution Channel
The point of care infectious disease market is analyzed and market size insights and trends are provided by country, type, technology, availability, application, distribution channel and end-user as referenced above.
The countries covered in the point of care infectious disease market report are Brazil, Argentina and Rest of South America as part of South America.
Brazil is dominating in the region due to high focus of government towards improvement of population health. The high prevalence of infectious diseases poses difficulties to authorities in achieving the goal of a healthy population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The point of care infectious disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point of care infectious disease market.
Point of Care Infectious Disease Market Leaders Operating in the Market Are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.